title: State of the science: Emerging therapeutic strategies for targeting angiogenesis in ovarian cancer.
authors.affiliation: Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Medical University of South Carolina, Charleston, SC, United States.
authors.forename: Whitney
authors.initials: W
authors.lastname: Graybill
authors.affiliation: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
authors.forename: Anil K
authors.initials: AK
authors.lastname: Sood
authors.affiliation: Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Creighton University, Phoenix, AZ, United States.
authors.forename: Bradley J
authors.initials: BJ
authors.lastname: Monk
authors.affiliation: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: rcoleman@mdanderson.org.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Coleman
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009389:Neovascularization, Pathologic / Q000628:therapy; D010051:Ovarian Neoplasms / Q000098:blood supply* / Q000188:drug therapy*